Shockwave Medical Closes $45M Series C Financing

Funding Rounds

▤ Summary

Shockwave Medical, a Fremont, Calif.-based developer of treatments for calcified cardiovascular disease, closed a $45m Series C financing.The round was led by Sectoral Asset Management, with participation from mutual funds advised by T. Rowe Price Associates, Inc. and existing investors Sofinnova Partners, Venrock, RA Capital, Deerfield, Ally Bridge Group and others.The company intends to use the funds to advance development of its Lithoplasty® balloon catheter platform into new therapeutic areas and to expand commercialization of the technology for the treatment of peripheral vascular disease in both the United States and the European Union.Built on a deliverable balloon catheter platform, the device emits intermittent sound waves (lithotripsy) that target and disrupt calcified plaques, which then require only a low-pressure balloon inflation to dilate the blockage and restore blood flow.The result is an effective and consistent revascularization of calcified lesions while minimizing complications.

$ Funding

$
Amount $45.0M Total raised
□
Date November 22, 2016 Announcement date
◎
Investors - Lead investors
▥
Company shockwave.com Funded company

▥ Classifications

industries
Entertainment
applications
Anti Piracy

◇ AskAI Classifications

Labels
Online Games Casual Games Downloadable Games

▦ Linked Companies